Publications by authors named "W Vogel"

Claim this Profile
N
Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial.
Sabine E Breukers, Joleen J H Traets, Stan W van Dijk, Mercedes Machuca Ostos, Itske Fraterman, Wouter V Vogel

Nat Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anatomical distribution of disease in pN1 prostate cancer with BCR post-RP: A PSMA-PET/CT-based analysis.
Lotte G Zuur, Katelijne C C de Bie, Lieke Wever, Anne-Claire Berrens, Jean-Paul A van Basten, Wouter V Vogel

BJUI Compass· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPECT/CT-based sentinel node procedure to guide unilateral elective nodal irradiation in patients with head and neck cancer: technical feasibility and sentinel node mapping outcomes.
Abrahim Al-Mamgani, Ellen Zwijnenburg, Luc Karssemakers, Emilia Owers, Jimmie Honing, Wouter V Vogel

Eur Arch Otorhinolaryngol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Capacity of Peri-Transplant Measurable Residual Disease Thresholds in NPM1-Mutant Acute Myeloid Leukemia.
Jan Schröder, Friederike Schwartz, Judith Metzdorf, Nick Barensteiner, Lucas Mix, Wichard Vogel

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial.
Sabine E Breukers, Robert D Crommelin, Laura A Smit, Jan Paul de Boer, Arash Navran, Wouter V Vogel

Eur J Nucl Med Mol Imaging· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis